-->
Trusting neighbors and community may aid smoking cessation in African-American smokers, accordingly to a study published in the Annals of Behavioral Medicine, a publication of the Society of Behavioral Medicine.
MD Anderson researchers collected data from 397 African-Americans seeking...
Patients with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that carries the Philadelphia chromosome (Ph+ALL) who can't tolerate...
Path-breaking targeted therapies have extended the lives of people with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that...
By Leslie Loddeke, Publications Coordinator, Melanoma Medical Oncology Department
MD Anderson Melanoma Medical Oncology Chair Patrick Hwu, M.D., and Professor Wen-Jen Hwu, M.D., Ph.D., were coauthors of one of the papers named in Nature Medicine's "Notable advances 2012" list of the year's top basic biomedical discoveries.
The article notes "certain areas of biomedicine saw fast-paced...
An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable...
-->
A new technique for expanding blood stem cells from umbilical cords in the lab before transplanting them into a patient reduces...
A drug approved for treating resistant versions of two types of lymphoma knocked down the disease in all 26 patients evaluated in a phase...
Updated: 4:30 p.m. Friday, Dec. 14
The U.S. Food and Drug Administration approved ponatinib (Iclusig) for chronic myeloid leukemia...
Elnar Koseoglu of Physician Relations and Bradley Swinney of Banner MD Anderson await the afternoon rush at booth 3500 in the exhibition hall...
Fifty years from now when an author is compiling a review of modern cancer therapy for a historical publication, he'll undoubtedly recognize...
Two papers published by MD Anderson clinical researchers are included in the American Society of Clinical Oncology's report, Clinical Cancer...
Updated Dec. 3, 2012
MD Anderson has six new Fellows in the American Association for the Advancement of Science, elected by their peers...
A protein that sneaks into the cell nucleus and sets off two separate cancer-promoting processes vital to the development of malignant brain...
A grimmer prognosis awaits African-Americans when compared to Caucasian patients suffering from renal cell carcinoma (RCC), the most common...
An effective drug that kills cancer by damaging DNA also attacks heart muscle, which for some patients leads to...
According to data from the National Cancer Institute's SEER database, less than 50% of patients with stage three bladder cancer will survive...
A simple measure of liver function routinely taken via blood tests at physical exams and other doctor's visits turns out to be highly predictive...
One of the most collaborative meetings of researchers in basic, clinical, behavioral and epidemiological science focused on cancer prevention...
Lynda Chin, M.D., professor and chair of MD Anderson's Department of Genomic Medicine and scientific director of the Institute for Applied...
The Holy Grail of oncology is personalized cancer therapy. While patients with either malignant ovarian germ cell tumors or ovarian sex cord-stromal...
When missing segments of the genome matter in cancer, it's bad news because those deletions have wiped out a gene that blocks or hinders cancer...
In 2008, MD Anderson Professor of Laboratory Medicine Xiang-Yang Han, M.D., Ph.D., and colleagues discovered the second species of bacterium...
I grew up playing games with my friends. I wanted to play any kind of physical game (sports), or board games (Stratego, Monopoly, Battleship...
A select number of high-risk pancreatic cancer patients initially deemed inoperable are, in fact, eligible for surgery and have a chance for...
During the next two decades, breast cancer diagnoses in older women are expected to increase by 57%. It's a reality that highlights the importance...
The protein Grb2, once considered merely a passive link between other proteins, acts as an on-off switch for a critical growth signaling pathway...
A gene most commonly known as a tumor-suppressor appears to help breast cancer cells survive treatment by a common chemotherapy drug.
<...The Annual American Society of Clinical Oncology (ASCO) meeting will be discussing several new drugs in development. We have been investigating...
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients...
MD Anderson has launched a new course on The Professional Oncology Education site. Colorectal Cancer Survivorship is funded by a grant from...
Cancer stem cells, a small subgroup of hard-core tumor cells capable of both self-renewal and tumor generation, are hard to find, let alone...
While discussion continues over the value of screening healthy men for prostate cancer by testing for levels of prostate specific antigen...
When 3,000 participants lineup Saturday for the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run they'll take thousands...
More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive appropriate...
An antibody created at MD Anderson blocks the life-threatening gastrointestinal damage caused by high levels of radiation - so far in mice...
Patrick Hwu, M.D., head of MD Anderson's Department of Melanoma Medical Oncology, presented evidence supporting the combination of BRAF inhibitors...
A creative plan to identify new drugs to prevent cancer has earned an MD Anderson scientist a prominent national award to support her research...
A vaccine that targets the HER2 protein has triggered immune responses among patients in a phase II clinical trial to prevent recurrence of...
A combination of two targeted therapies reduces tumors in treatment-resistant Ewing's sarcoma, a bone cancer that mainly strikes children,...
Abnormal activation or production of four proteins involved in translation, the final step of creating other proteins, are associated with...
An innovative approach to targeting the blood vessels that support neuroendocrine tumors of the pancreas has earned the support of a major...
The American Association for Cancer Research will present its sixth annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements...
We have known for the past two decades that aspirin and non-steroidal anti-inflammatory drug (NSAID) use reduces the risk of colorectal and...
Researchers have caught two molecular signaling networks engaged in "crosstalk" that undermines attempts to successfully target cancer-promoting...
Tobacco use has long been known to cause lung cancer and increased morbidity in smokers. A study sponsored by the National Cancer Institute...
At an early age, children are naturally physically active, full of energy and often find joy in running and jumping in an unstructured environment...
Myelofibrosis, a lethal bone marrow malignancy, comes with especially debilitating symptoms that sap a patient's quality of life.
...
The Sixth International Conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases was held at the Dan Duncan building...
About 20 years ago, I started medical practice with no intention of pursuing research.
As the most junior person, I was asked to take...
It started with a clinical observation: Why do so many ovarian cancer patients have such high levels of circulating platelets? As it turns...
University of Texas MD Anderson Cancer Center graduate student Geoffrey Grandjean's image of ovarian cancer cells is visually striking, scientifically...
The incidence of testicular cancer has increased steadily in recent years, but the cause has been elusive. MD Anderson Cancer Center scientists...
Read between the lines and you'll find an MD Anderson Cancer Center connection to one of Discover's top 100 stories of 2011, announced in...
Andrew Schorr is a pioneer in health communications and patient education and, along the way, became a patient himself. Andrew was diagnosed...
A study led by Melanoma Medical Oncology Department researcher Michael A. Davies, M.D., Ph.D., published in the journal Cancer identifies...
A new 14-gene assay shows promise as a predictor of which early stage lung cancer patients may need chemotherapy because their disease is...
Kras, an influential gene that serves as an on-off switch for other genes, is mutated in 80 to 95% of cases of pancreatic cancer.
"...
Chronic inflammation and the chemical silencing of tumor-suppressing genes have long been known to influence development and progression of...